ASK-M , together with Consultask and Ateknea Solutions, conform to the commitment, has completed and submitted the final report of the Phase I. of the EU H2020 SME Instrument, Clinical Validaton topic, where it has been selected for funding.
As the project is in the Technology Readiness Level required by the EU Call, we did not require the available 6 months time to accomplish and document this Phase, but have prepared all required documentation within 3 months. The report has been submitted in January, according to the originally voluntarily suggested deadline.
The report has been approved, the second (final) instalment of the funding is under processing, and the Team is preparing for submission for Phase II.
Due to the maturity of the project and the experience behind the current status, this is probably going to be one of the first Phase II submissions, following successful completion of Phase I. This is conform to the intention of the EU, completing the 3 Phases in succession, despite the possibility to apply directly for Phase II. We sincerely hope, that this circumstances, and mainly the scientific, technological and business potential merits of the project, together with the professionalism of our partners, will lead to a successful Phase II application.